Evodiamine induces apoptosis and inhibits migration of HCT-116 human colorectal cancer cells

International Journal of Molecular Sciences

Volumn 16, Issue 11, 2015, Pages 27411-27421

  Zhao, Lv Cui ^a   Li, Jing ^a   Liao, Ke ^b   Luo, Nian ^a   Shi, Qing Qiang ^a   Feng, Zi Qiang ^a   Chen, Di Long ^a  

^a CHONGQING MEDICAL UNIVERSITY   (China)

^b Chengdu Friendship Hospital   (China)

Author keywords

Anti cancer effects; Evodiamine (EVO); HCT 116 cells; Molecular mechanisms

Indexed keywords

CYCLIN A1; EVODIAMINE; GLUCOSE 6 PHOSPHATE ISOMERASE; N BENZYL 2 CYANO 3 (3, 4 DIHYDROXYPHENYL) ACRYLAMIDE; PROTEIN BAX; PROTEIN BCL 2; PROTEIN P53; STAT3 PROTEIN; STROMELYSIN; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT; CELL CYCLE PROTEIN; JANUS KINASE 2; PLANT EXTRACT; PROTEIN KINASE INHIBITOR; QUINAZOLINE DERIVATIVE;

APOPTOSIS; ARTICLE; CELL CYCLE ARREST; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL CYCLE S PHASE; CELL MIGRATION; CELL VIABILITY ASSAY; COLORECTAL CANCER; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; GENE SILENCING; HUMAN; HUMAN CELL; IMMUNOBLOTTING; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; WESTERN BLOTTING; ANTAGONISTS AND INHIBITORS; CELL CYCLE CHECKPOINT; CELL MOTION; CELL PROLIFERATION; COLORECTAL TUMOR; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; HCT 116 CELL LINE; METABOLISM; PATHOLOGY;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; CELL CYCLE CHECKPOINTS; CELL CYCLE PROTEINS; CELL MOVEMENT; CELL PROLIFERATION; COLORECTAL NEOPLASMS; GENE EXPRESSION REGULATION, NEOPLASTIC; HCT116 CELLS; HUMANS; JANUS KINASE 2; PLANT EXTRACTS; PROTEIN KINASE INHIBITORS; QUINAZOLINES; SIGNAL TRANSDUCTION;

EID: 84947420825     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms161126031     Document Type: Article

References (33)

1. Swiderska, M.; Choromanska, B.; Dabrowska, E.; Konarzewska-Duchnowska, E.; Chorománska, K.; Szczurko, G.; Mýsliwiec, P.; Dadan, J.; Ładny, J.R.; Zwierz, K. The diagnostics of colorectal cancer. Contemp. Oncol. 2014, 18, 1-6.
2. Gupta, G.P.; Massagué, J. Cancer metastasis: Building a framework. Cell 2006, 127, 679-695
3. Zhang, C.; Fan, X.; Xu, X.; Yang, X.; Wang, X.; Liang, H.P. Evodiamine induces caspase-dependent apoptosis and S phase arrest in human colon lovo cells. Anticancer Drugs 2010, 21, 766-776
4. kB signaling pathways and augmented by ubiquitin-proteasome inhibition. Toxicol. Vitro 2010, 24, 898-904
5. Yang, J.; Wu, L.J.; Tashino, S.; Onodera, S.; Ikejima, T. Reactive oxygen species and nitric oxide regulate mitochondria-dependent apoptosis and autophagy in evodiamine-treated human cervix carcinoma HeLa cells. Free Radic. Res. 2008, 42, 492-504
6. Jiang, J.; Hu, C. Evodiamine: A novel anti-cancer alkaloid from Evodia rutaecarpa. Molecules 2009, 14, 1852-1859
7. Zheng, X.; He, K.; Zhang, L.; Yu, J. Crizotinib induces PUMA-dependent apoptosis in colon cancer cells. Mol. Cancer Ther. 2013, 12, 777-786
8. Harder, J.M.; Libby, R.T. BBC3 (PUMA) regulates developmental apoptosis but not axonal injury induced death in the retina. Mol. Neurodegener. 2011, 6
9. Yu, F.L.; Liao, M.H.; Lee, J.W.; Shih, W.L. Induction of hepatoma cells migration by phosphoglucose isomerase/autocrine motility factor through the upregulation of matrix metalloproteinase-3. Biochem. Biophys. Res. Commun. 2004, 314, 76-82
10. Niinaka, Y.; Harada, K.; Fujimuro, M.; Oda, M.; Haga, A.; Hosoki, M.; Uzawa, N.; Arai, N.; Yamaguchi, S.; Yamashiro, M.; et al. Silencing of autocrine motility factor induces mesenchymal-to-epithelial transition and suppression of osteosarcoma pulmonary metastasis. Cancer Res. 2010, 70, 9483-9493
11. Gurbuz, V.; Konac, E.; Varol, N.; Yilmaz, A.; Gurocak, S.; Menevse, S.; Sozen, S. Effects of AG490 and S3I-201 on regulation of the JAK/STAT3 signaling pathway in relation to angiogenesis in TRAIL-resistant prostate cancer cells. Oncol. Lett. 2014, 7, 755-763
12. Germain, D.; Frank, D.A. Targeting the cytoplasmic and nuclear functions of signal transducers and activators of transcription 3 for cancer therapy. Clin. Cancer Res. 2007, 13, 5665-5669
13. Yu, H.; Jove, R. The STATs of cancer-New molecular targets come of age. Nat. Rev. Cancer 2004, 4, 97-105
14. Shih, W.L.; Liao, M.H.; Yu, F.L.; Lin, P.Y.; Hsu, H.Y.; Chiu, S.J. AMF/PGI transactivates the MMP-3 gene through the activation of Src-RhoA-phosphatidylinositol 3-kinase signaling to induce hepatoma cell migration. Cancer Lett. 2008, 270, 202-217
15. Liu, M.; Wilson, N.O.; Hibbert, J.M.; Stiles, J.K. STAT3 regulates MMP3 in heme-induced endothelial cell apoptosis. PLoS ONE 2013, 8, e71366
16. Gao, W.; McCormick, J.; Connolly, M.; Balogh, E.; Veale, D.J.; Fearon, U. Hypoxia and STAT3 signalling interactions regulate pro-inflammatory pathways in rheumatoid arthritis. Ann. Rheum. Dis. 2014
17. Liotta, L.A.; Mandler, R.; Murano, G.; Katz, D.A.; Gordon, R.K.; Chiang, P.K.; Schiffmann, E. Tumor cell autocrine motility factor. Proc. Natl. Acad. Sci. USA 1986, 83, 3302-3306
18. Kan, S.F.; Yu, C.H.; Pu, H.F.; Hsu, J.M.; Chen, M.J.; Wang, P.S. Anti-proliferative effects of evodiamine on human prostate cancer cell lines DU145 and PC3. J. Cell. Biochem. 2007, 101, 44-56
19. Xu, M.L.; Li, G.; Moon, D.C.; Lee, C.S.; Woo, M.H.; Lee, E.S.; Jahng, Y.; Chang, H.W.; Lee, S.H.; Son, J.K. Cytotoxicity and DNA topoisomerase inhibitory activity of constituents isolated from the fruits of Evodia officinalis. Arch. Pharm. Res. 2006, 29, 541-547
20. Lee, T.J.; Kim, E.J.; Kim, S.; Jung, E.M.; Park, J.W.; Jeong, S.H.; Park, S.E.; Yoo, Y.H.; Kwon, T.K. Caspase-dependent and caspase-independent apoptosis induced by evodiamine in human leukemic U937 cells. Mol. Cancer Ther. 2006, 5, 2398-2407
21. Du, J.; Wang, X.F.; Zhou, Q.M.; Zhang, T.L.; Lu, Y.Y.; Zhang, H.; Su, S.B. Evodiamine induces apoptosis and inhibits metastasis in MDAMB-231 human breast cancer cells in vitro and in vivo. Oncol. Rep. 2013, 30, 685-694
22. Yang, J.; Cai, X.; Lu, W.; Hu, C.; Xu, X.; Yu, Q.; Cao, P. Evodiamine inhibits STAT3 signaling by inducing phosphatase shatterproof 1 in hepatocellular carcinoma cells. Cancer Lett. 2013, 328, 243-251
23. Shaw, R.J.; Liloglou, T.; Rogers, S.N.; Brown, J.S.; Vaughan, E.D.; Lowe, D.; Field, J.K.; Risk, J.M. Promoter methylation of P16, RARβ, E-cadherin, cyclin A1 and cytoglobin in oral cancer: Quantitative evaluation using pyrosequencing. Br. J. Cancer 2006, 94, 561-568
24. Faik, P.; Walker, J.I.; Redmill, A.A.; Morgan, M.J. Mouse glucose-6-phosphate isomerase and neuroleukin have identical 31 sequences. Nature 1988, 332, 455-457
25. Watanabe, H.; Takehana, K.; Date, M.; Shinozaki, T.; Raz, A. Tumor cell autocrine motility factor is the neuroleukin/phosphohexose isomerase polypeptide. Cancer Res. 1996, 56, 2960-2963
26. Turkson, J.; Jove, R. STAT proteins: Novel molecular targets for cancer drug discovery. Oncogene 2000, 19, 6613-6626
27. Turkson, J.; Bowman, T.; Garcia, R.; Caldenhoven, E.; de Groot, R.P.; Jove, R. STAT3 activation by Src induces specific gene regulation and is required for cell transformation. Mol. Cell. Biol. 1998, 18, 2545-2552
28. Chen, Z.; Han, Z.C. STAT3: A critical transcription activator in angiogenesis. Med. Res. Rev. 2008, 28, 185-200
29. Devarajan, E.; Huang, S. STAT3 as a central regulator of tumor metastases. Curr. Mol. Med. 2009, 9, 626-633
30. Shih, W.L.; Liao, M.H.; Lin, P.Y.; Chang, C.I.; Cheng, H.L.; Yu, F.L.; Lee, J.W. PI 3-kinase/Akt and STAT3 are required for the prevention of TGF-β-induced Hep3B cell apoptosis by autocrine motility factor/phosphoglucose isomerase. Cancer Lett. 2010, 290, 223-237
31. Yu, H.; Lee, H.; Herrmann, A.; Buettner, R.; Jove, R. Revisiting STAT3 signalling in cancer: New and unexpected biological functions. Nat. Rev. Cancer 2014, 14, 736-746
32. Hong, J.Y.; Park, S.H.; Min, H.Y.; Park, H.J.; Lee, S.K. Anti-proliferative effects of evodiamine in human lung cancer cells. J. Cancer Prev. 2014, 19, 7-13
33. Chen, M.C.; Yu, C.H.; Wang, S.W.; Pu, H.F.; Kan, S.F.; Lin, L.C.; Chi, C.W.; Ho, L.L.; Lee, C.H.; Wang, P.S. Anti-proliferative effects of evodiamine on human thyroid cancer cell line ARO. J. Cell. Biochem. 2010, 110, 1495-1503